People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

27.05USD
19 Dec 2014
Price Change (% chg)

$0.07 (+0.26%)
Prev Close
$26.98
Open
$26.98
Day's High
$27.85
Day's Low
$26.40
Volume
706,975
Avg. Vol
210,463
52-wk High
$28.48
52-wk Low
$19.31

Search Stocks

Niederhuber, John 

Brief Biography

Dr. John E. Niederhuber, M.D., is an Independent Director of Emergent BioSolutions Inc. He previously served as the director of the National Cancer Institute, or NCI, from 2005 to 2010. Dr. Niederhuber joined Inova Health System in August 2010 as Executive Vice President and CEO of the Inova Institute for Translational Research and Personalized Medicine. Dr. Niederhuber is also an adjunct investigator at NCI’s Center for Cancer Research, studying factors in the tumor microenvironment that lead to increased malignancy. He currently serves on the board of directors of Novelos Therapeutics, Inc. Prior to joining NCI, Dr. Niederhuber was Director of the University of Wisconsin Comprehensive Cancer Center and a professor of surgery and oncology (member of the McArdle Laboratory) at the University of Wisconsin School of Medicine from 1997 to 2005. He chaired the Department of Surgery at Stanford University from 1991 to 1997 and held professorships at the Johns Hopkins University School of Medicine from 1987 to 1991 and at the University of Michigan from 1973 to 1987. Dr. Niederhuber is a graduate of Bethany College in West Virginia and the Ohio State University School of Medicine.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fuad El-Hibri

1,295,470

Daniel Abdun-Nabi

2,160,850

Robert Kramer

800,747

Anatolio Cruz

--

Adam Havey

805,364

Barry Labinger

138,944
As Of 30 Dec 2013
Search Stocks